233 related articles for article (PubMed ID: 27836119)
21. Multi-institutional retrospective study of mucoepidermoid carcinoma treated with carbon-ion radiotherapy.
Shirai K; Koto M; Demizu Y; Suefuji H; Ohno T; Tsuji H; Okimoto T; Shioyama Y; Saitoh JI; Nemoto K; Nakano T; Kamada T;
Cancer Sci; 2017 Jul; 108(7):1447-1451. PubMed ID: 28474791
[TBL] [Abstract][Full Text] [Related]
22. A prospective nonrandomized phase I/II study of carbon ion radiotherapy in a favorable subset of locally advanced non-small cell lung cancer (NSCLC).
Takahashi W; Nakajima M; Yamamoto N; Yamashita H; Nakagawa K; Miyamoto T; Tsuji H; Kamada T; Fujisawa T
Cancer; 2015 Apr; 121(8):1321-7. PubMed ID: 25641119
[TBL] [Abstract][Full Text] [Related]
23. Feasibility of carbon ion radiotherapy for locally advanced sinonasal adenocarcinoma.
Koto M; Hasegawa A; Takagi R; Sasahara G; Ikawa H; Mizoe JE; Jingu K; Tsujii H; Kamada T; Okamoto Y;
Radiother Oncol; 2014 Oct; 113(1):60-5. PubMed ID: 25287484
[TBL] [Abstract][Full Text] [Related]
24. Carbon-ion radiotherapy for lymph node oligo-recurrence: a multi-institutional study by the Japan Carbon-Ion Radiation Oncology Study Group (J-CROS).
Okonogi N; Kaminuma T; Okimoto T; Shinoto M; Yamamoto N; Yamada S; Murata K; Ohno T; Shioyama Y; Tsuji H; Nakano T; Kamada T
Int J Clin Oncol; 2019 Sep; 24(9):1143-1150. PubMed ID: 30968270
[TBL] [Abstract][Full Text] [Related]
25. Short-course carbon-ion radiotherapy for hepatocellular carcinoma: A multi-institutional retrospective study.
Shibuya K; Ohno T; Terashima K; Toyama S; Yasuda S; Tsuji H; Okimoto T; Shioyama Y; Nemoto K; Kamada T; Nakano T;
Liver Int; 2018 Dec; 38(12):2239-2247. PubMed ID: 30240527
[TBL] [Abstract][Full Text] [Related]
26. Functional imaging-guided carbon ion irradiation with simultaneous integrated boost for localized prostate cancer: study protocol for a phase II randomized controlled clinical trial.
Hu W; Li P; Hong Z; Guo X; Pei Y; Zhang Z; Zhang Q
Trials; 2022 Nov; 23(1):934. PubMed ID: 36348363
[TBL] [Abstract][Full Text] [Related]
27. Outcomes of hypofractionated stereotactic body radiotherapy boost for intermediate and high-risk prostate cancer.
Anwar M; Weinberg V; Seymour Z; Hsu IJ; Roach M; Gottschalk AR
Radiat Oncol; 2016 Jan; 11():8. PubMed ID: 26792201
[TBL] [Abstract][Full Text] [Related]
28. Significant impact of biochemical recurrence on overall mortality in patients with high-risk prostate cancer after carbon-ion radiotherapy combined with androgen deprivation therapy.
Kasuya G; Ishikawa H; Tsuji H; Nomiya T; Makishima H; Kamada T; Akakura K; Suzuki H; Shimazaki J; Haruyama Y; Kobashi G; Tsujii H;
Cancer; 2016 Oct; 122(20):3225-3231. PubMed ID: 27351298
[TBL] [Abstract][Full Text] [Related]
29. Toxicity after external beam radiotherapy for prostate cancer: an analysis of late morbidity in men with diabetes mellitus.
Kalakota K; Liauw SL
Urology; 2013 Jun; 81(6):1196-201. PubMed ID: 23540863
[TBL] [Abstract][Full Text] [Related]
30. Nationwide multi-institutional retrospective analysis of high-dose-rate brachytherapy combined with external beam radiotherapy for localized prostate cancer: An Asian Prostate HDR-BT Consortium.
Ishiyama H; Kamitani N; Kawamura H; Kato S; Aoki M; Kariya S; Matsumura T; Kaidu M; Yoshida K; Hashimoto Y; Noda Y; Lim KHC; Kawase T; Takahashi T; Inaba K; Kumano M; Yoshikawa N; Yoshioka Y; Nakamura K; Hiratsuka J; Itami J; Hayakawa K
Brachytherapy; 2017; 16(3):503-510. PubMed ID: 28222973
[TBL] [Abstract][Full Text] [Related]
31. Urinary and Rectal Toxicity Profiles After Permanent Iodine-125 Implant Brachytherapy in Japanese Men: Nationwide J-POPS Multi-institutional Prospective Cohort Study.
Ohashi T; Yorozu A; Saito S; Tanaka N; Katayama N; Kojima S; Maruo S; Kikuchi T; Dokiya T; Fukushima M; Yamanaka H
Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):141-9. PubMed ID: 26279031
[TBL] [Abstract][Full Text] [Related]
32. Morbidity and prostate-specific antigen control of external beam radiation therapy plus low-dose-rate brachytherapy boost for low, intermediate, and high-risk prostate cancer.
Koontz BF; Chino J; Lee WR; Hahn CA; Buckley N; Huang S; Kim J; Reagan R; Joyner R; Anscher MS
Brachytherapy; 2009; 8(2):191-196. PubMed ID: 19433320
[TBL] [Abstract][Full Text] [Related]
33. Prospective Phase II Trial of Once-weekly Hypofractionated Radiation Therapy for Low-risk Adenocarcinoma of the Prostate: Late Toxicities and Outcomes.
Zimmermann M; Taussky D; Menkarios C; Vigneault É; Beauchemin MC; Bahary JP; Martin AA; Diaz de Bedoya LV; Lambert C
Clin Oncol (R Coll Radiol); 2016 Jun; 28(6):386-92. PubMed ID: 26782838
[TBL] [Abstract][Full Text] [Related]
34. Long-term results of a prospective, Phase II study of long-term androgen ablation, pelvic radiotherapy, brachytherapy boost, and adjuvant docetaxel in patients with high-risk prostate cancer.
Dibiase SJ; Hussain A; Kataria R; Amin P; Bassi S; Dawson N; Kwok Y
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):732-6. PubMed ID: 21036486
[TBL] [Abstract][Full Text] [Related]
35. [Particle beam radiotherapy].
Saitoh J; Nakano T
Gan To Kagaku Ryoho; 2014 Dec; 41(13):2546-9. PubMed ID: 25596047
[TBL] [Abstract][Full Text] [Related]
36. Single-Fraction Carbon-Ion Radiation Therapy for Patients 80 Years of Age and Older With Stage I Non-Small Cell Lung Cancer.
Karube M; Yamamoto N; Nakajima M; Yamashita H; Nakagawa K; Miyamoto T; Tsuji H; Fujisawa T; Kamada T
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):542-548. PubMed ID: 26797538
[TBL] [Abstract][Full Text] [Related]
37. Carbon-ion radiotherapy for cholangiocarcinoma: a multi-institutional study by and the Japan carbon-ion radiation oncology study group (J-CROS).
Kasuya G; Terashima K; Shibuya K; Toyama S; Ebner DK; Tsuji H; Okimoto T; Ohno T; Shioyama Y; Nakano T; Kamada T;
Oncotarget; 2019 Jul; 10(43):4369-4379. PubMed ID: 31320991
[TBL] [Abstract][Full Text] [Related]
38. Two-Year Toxicity and Efficacy of Carbon Ion Radiotherapy in the Treatment of Localized Prostate Cancer: A Single-Centered Study.
Li P; Hong Z; Li Y; Fu S; Zhang Q
Front Oncol; 2021; 11():808216. PubMed ID: 35223457
[TBL] [Abstract][Full Text] [Related]
39. Salvage surgery for local recurrence after carbon ion radiotherapy for patients with lung cancer.
Mizobuchi T; Yamamoto N; Nakajima M; Baba M; Miyoshi K; Nakayama H; Watanabe S; Katoh R; Kohno T; Kamiyoshihara M; Nishio W; Kamada T; Fujisawa T; Yoshino I
Eur J Cardiothorac Surg; 2016 May; 49(5):1503-9. PubMed ID: 26468271
[TBL] [Abstract][Full Text] [Related]
40. Long term results of a prospective dose escalation phase-II trial: interstitial pulsed-dose-rate brachytherapy as boost for intermediate- and high-risk prostate cancer.
Lettmaier S; Lotter M; Kreppner S; Strnad A; Fietkau R; Strnad V
Radiother Oncol; 2012 Aug; 104(2):181-6. PubMed ID: 22853851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
